Roche is launching a Phase 3 trial of the controversial Duchenne gene therapy Elevidys, hoping it could lead to approval in ...
MHH Human Genetics is improving the diagnosis of rare diseases in order to tailor treatments for critically ill newborns and children.
Climate Compass on MSN
The 8 breakthroughs that could quietly change everyday life
Most of the developments that end up reshaping daily life don't announce themselves with fanfare. They start in laboratories, ...
A concise, high-yield guide to cholesterol-lowering therapies—statins, Zetia, PCSK9 inhibitors, bempedoic acid, berberine, ...
The United Kingdom has long been a powerhouse in the pharmaceutical and biotechnology sectors, but recent developments have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results